RPRX
NASDAQ · Pharmaceuticals
Royalty Pharma Plc- Cl A
$67.30
-0.27 (-0.40%)
Performance
1D
—
1W
+1.17%
1M
+16.48%
3M
+16.46%
6M
+26.38%
1Y
+74.62%
YTD
+73.19%
Open$66.52
Previous Close$67.57
Day High$68.15
Day Low$66.52
52W High$69.77
52W Low$36.03
Volume—
Avg Volume3.51M
Market Cap38.68B
P/E Ratio47.46
EPS$1.46
SectorPharmaceuticals
Technical Indicators
Full analysis →
SMA 50
$60.82
Above
SMA 200
$53.91
Above
RSI (14)
84.3
Overbought
Trend
Golden Cross
Bullish
Analyst Ratings
Strong Buy
14 analysts
Price Target
-46.1% upside
Current
$67.30
$67.30
Target
$36.26
$36.26
$26.65
$36.26 avg
$40.53
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 2.42B | 2.37B | 6.69B |
| Net Income | 785.02M | 692.25M | 946.13M |
| Profit Margin | 32.4% | 30.8% | 14.1% |
| EBITDA | 1.59B | 1.48B | 1.13B |
| Free Cash Flow | — | — | 700.09M |
| Rev Growth | +2.1% | +2.1% | +2.6% |
| Debt/Equity | 1.38 | 1.38 | 0.41 |
Dividend
Dividend Yield2.96%
Annual Dividend$0.65
Payout Ratio49.1%
Frequencyquarterly
Ex-Dividend—
Pay Date—
Pharmaceuticals Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| LLY | Eli Lilly and Co. | $1,403.15 | +3.63% | 46.6 | 1.28T |
| JNJ | Johnson & Johnson | $281.29 | +1.84% | 40.8 | 656.45B |
| MRK | Merck & Co. Inc. | $147.81 | +0.74% | 147.8 | 362.53B |
| PFE | Pfizer Inc. | $29.47 | +0.27% | 41.4 | 167.12B |
| BMY | Bristol-Myers Squibb Co | $62.14 | -1.57% | 13.8 | 127.96B |
| ZTS | Zoetis Inc | $82.35 | +3.72% | 12.8 | 33.59B |